Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer's Crizontinib Shows Promise

Premium

Researchers at the Dana-Farber Cancer Institute and their colleagues report positive results for Pfizer's crizontinib, a compound the firm is developing for the treatment of ALK-positive inflammatory myofibroblastic tumors, in a New England Journal of Medicine paper published last week. Because "several ALK fusion proteins, including TPM3-ALK found in IMT, induce transformation in cell lines and animal models, a finding that suggests that ALK rearrangement may define a subgroup of IMTs that is sensitive to targeted kinase inhibition," the team writes, they decided to test the efficacy of crizotinib — ATP-competitive inhibitor of the ALK and MET tyrosine kinases — in two patients with IMTs: one who had a rearrangement in the ALK gene on chromosome 2p23, and one who did not. Post-crizotinib treatment, the former patient's tumors showed shrinking, while the latter patient's tumors showed no improvement, the team reports. Based on these test cases, the Dana-Farber team suggests that signal transduction in a subgroup of IMTs is dependent upin ALK-mediated signal transduction. In noting that " crizotinib has also shown striking clinical activity in non-small-cell lung cancers with EML4-ALK rearrangements," the authors say that "the use of targeted inhibitors to disrupt mutant signaling pathways that cancers require for continued growth has resulted in substantial progress in cancer treatment."

HT: Robert Langreth at Forbes' Treatments

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.